Arrowhead Research | Spese Operative



Operating Expenses Cambiamento Data
Agios Pharmaceuticals USD 115.35M 20.41M 2025-03
Alnylam Pharmaceuticals USD 576.11M 122.21M 2025-03
Arrowhead Research USD 163.91M 1.71M 2024-12
Incyte USD 847.73M 29.46M 2025-03
Ionis Pharmaceuticals USD 278M 59.4M 2025-03
Ligand Pharmaceuticals USD 52.45M 3.78M 2024-12
Merck USD 9.66B 1.67B 2025-03
Moderna USD 1.16B 1.06B 2025-03
Novartis USD 11.28B 1.73B 2024-12
Sarepta Therapeutics USD 496.73M 51.76M 2024-12
TG Therapeutics USD 78.24M 6.79M 2024-12
Ultragenyx Pharmaceutical USD 287.15M 15.67M 2024-12
Vertex Pharmaceuticals USD 1.89B 230.4M 2024-12
Xencor USD 65.97M 7.02M 2024-12



Arrowhead Research Spese Operative - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.